Skip to content

Hospital Medicine Virtual Journal Club

Menu

Search for:

About
Archives
FAQs
How to Access Full-text Articles
How to Use
Privacy Policy and Terms of Use

Category: trends immunol

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.

trends immunol • April 7, 2020

Follow Us!

Journal Club via Email

Sign up for Email updates!

The HMVJC Minute Podcast

	
	
		

Subscribe Now!


	Anchor
Apple Podcasts
Breaker
Google Podcasts
iHeartRadio
PocketCasts
Podbay
Radio Public
Spotify
TikTok
YouTube

Recent Comments

Ronald M. Chavin on What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak
An Examination of Ivermectin and Other Promising Medications in the Prevention and Treatment of COVID | Compounding Corner Pharmacy, Inc. on Montelukast in Hospitalized Patients Diagnosed with COVID-19
Nathan Martin on Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial
Anonymous on What is the role of remdesivir in patients with COVID-19?
Nathan Martin on Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

The HMVJC COVID Reading List

The effect of ivermectin on non-severe and severe COVID-19 disease and gender-based difference of its effectiveness
Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial
Hospitalizations for COVID-19 Among US People Experiencing Incarceration or Homelessness
Safety and Efficacy of Tocilizumab 4 or 8 mg/kg in Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019 Pneumonia: A Randomized Clinical Trial
Patients diagnosed with COVID-19 and treated with anakinra: a real-world study in the USA
Effect of convalescent plasma as complementary treatment in patients with moderate COVID-19 infection
Comparison of patient characteristics and in-hospital mortality between patients with COVID-19 in 2020 and those with influenza in 2017-2020: a multicenter, retrospective cohort study in Japan
A Randomized Clinical Trial of Linagliptin vs. Standard of Care in Patients Hospitalized With Diabetes and COVID-19
Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial
Anticoagulation Management and Outcomes in Patients With Covid-19 With Propensity Score Matching: A Multicenter Retrospective Cohort Study

Links

WU School of Medicine
Dept. of Medicine
Division of Hospital Medicine
Becker Medical Library
Society of Hospital Medicine
Today's Hospitalist

Editor: Robert J. Mahoney, M.D., CCS-P, SFHM

Powered by
PubMed

©2022 Washington University in St. Louis